Previous Section | Index | Home Page |
John Mann: To ask the Secretary of State for Health when she intends to publish the full evaluation of the school fruit and vegetable scheme undertaken by the National Foundation of Educational Research; and what funds her Department has allocated to the scheme beyond 200506. [6505]
Caroline Flint: The Big Lottery Fund commissioned the National Foundation for Educational Research to carry out the evaluation of the school fruit and vegetable scheme. The Big Lottery Fund expect to publish the final report on their website by the end of August.
An announcement on future funding for the school fruit and vegetable scheme will be made once we have considered the findings from the evaluation.
Paul Flynn: To ask the Secretary of State for Health what her Department's advice is on the prescribing of (a) Seroxat and (b) other selective serotonin reuptake inhibitors. [11319]
Jane Kennedy: On 6 December 2004, a letter was sent to all health professionals in the United Kingdom from the Chairman of the Committee on Safety of Medicines announcing the results of the review of the safety of selective serotonin reuptake inhibitors (SSRIs), including Seroxat and providing prescribing advice for all SSRIs. A copy is available in the Library.
On the same day, the National Institute for Health and Clinical Excellence (NICE) published guidelines on the management of depression in primary care. These guidelines state that antidepressants, including SSRIs, are not recommended for the initial treatment of mild depressive illness because the risk-benefit ratio is poor.
Paul Flynn: To ask the Secretary of State for Health what percentage of the respondents to the consultation on the proposed reclassification of simvastatin as an over-the-counter drug were in favour of the proposal. [10850]
Jane Kennedy: Of the 100 responses received, about one third were supportive of the proposal, one third opposed and one third were not opposed but raised issues. This was the position put to the Committee on Safety of Medicines (CSM), which also had access to the full responses when giving its advice. The consultation raised no issues not already considered by the CSM when their advice to consult on making simvastatin 10 milligrammes (mg) available over the counter was formulated. An error in the summary placed on the website following the announcement of the decision to allow simvastatin 10 mg to be sold in pharmacies had no bearing on the robustness of the deliberations of the CSM.
Responses received to the consultation on the proposed reclassification of simvastatin as an over-the-counter medicine have been made available electronically or summarised on the Medicines and Healthcare products Regulatory Agency's (MHRA) website at:
To ensure complete transparency, the MHRA publishes the responses to all such consultationsmost recently for chloramphenicol eye drops.
Mark Tami: To ask the Secretary of State for Health (1) what guidance her Department provides regarding the prevention of skin cancer caused by over-exposure to the sun; [9215]
(2) how much has been spent by her Department on (a) advertisements and (b) materials to educate individuals on the effects of over-exposure to the sun. [9227]
Caroline Flint:
In 200304, the United Kingdom health departments provided £400,000 funding to Cancer Research UK to run the SunSmart" sun awareness campaign from 200304 for an initial three year period. The campaign aims to raise awareness of skin cancer, the symptoms to look out for and the simple steps on how to prevent it. Posters and information cards have been distributed to health professionals, all
13 Jul 2005 : Column 1147W
general practitioners' surgeries and schools, to reach as many people as possible with the five point SunSmart" message:
SunSmart" encourages people to protect themselves in the sun, thereby reducing their risk of skin cancer. This public education approach using primary care stakeholders has been very successful in Australia, where changes in attitude towards sun exposure and symptom recognition have reduced skin cancer mortality.
The SunSmart" campaign works primarily through the distribution of materials, public relations and strategy development, underpinned by research to provide an evidence base.
As Cancer Research UK does not use paid advertising in newsletters or papers as a primary communication tool, costs reflect activities such as promotional merchandise, web presence, sun awareness week activities, purchasing of distribution opportunities and conference presence. Estimates of the value of the coverage and reach generated by the campaign in 2004 are as follows:
The above does not include reach of free resource materials, but to print and radio coverage at nil cost.
Costs of materials include components for their development and design, printing, storage and distribution. Other costs relate to staff, including on costs, are shown in the table.
13 Jul 2005 : Column 1148W
Total contract | Staff costs | Advertising and promotion | Materials | |
---|---|---|---|---|
200304 | 110,000 | 26,000 | 14,500 | 61,000 |
200405 | 170,000 | 45,000 | 37,000 | 88,000 |
200506 | 175,000 | 48500 | 39,500 | 87,000 |
200607 | 180,000 | Unbudgeted at this stage |
John Cummings: To ask the Secretary of State for Health (1) if she will include in her consultation on the elements of forthcoming health improvement legislation relating to restrictions on smoking the option of designated smoking rooms in workplaces, including licensed premises; [11489]
(2) if she will include in her consultation on elements of forthcoming health improvement legislation relating to restrictions on smoking the designation of well-ventilated smoking rooms which are separated from both bar and eating areas. [11490]
Caroline Flint: The Government's proposals were set out in the White Paper, Choosing Health", in November 2004 for legislation for the vast majority of enclosed public places and workplaces to be smokefree.
Consultation on these proposals began on 20 June, when the consultation paper, Smokefree elements of the Health Improvement and Protection Bill", was published. A copy is available in the Library.
Mr. Amess: To ask the Secretary of State for Health how many (a) NHS clerical, administrative and management staff, (b) NHS hospital doctors and GPs and (c) NHS nurses and midwives there were in Southend Primary Care Trust in each year since 1990. [10533]
Ms Rosie Winterton: The available information is shown in the table.
Information for Southend Primary Care Trust (PCT) is only available from 2001, when the PCT came into existence. Figures by strategic health authority (SHA) are shown from 1992 for medical staff. Information about non-medical staff is only available from 1995.
Mr. Amess: To ask the Secretary of State for Health how much has been spent by Southend primary care trust on salaries and wages costs for (a) general and senior managers, (b) nurses and midwives and (c) administrative and clerical staff in each financial year since 199798. [10534]
Ms Rosie Winterton: Expenditure on salaries and wages by Southend primary care trust (PCT) for the occupational groups requested are shown in the following table.
Next Section | Index | Home Page |